Federica Guffanti
Milan, 20156, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 31, 2026
Protocol to study the antitumor and metabolic effects of intermittent fasting plus cisplatin and metformin in ovarian cancer PDX models.
Journal: STAR protocols
Published: March 27, 2026
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian Carcinomas.
Journal: International journal of molecular sciences
Published: March 20, 2025
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring.
Journal: Frontiers in oncology
Published: October 04, 2024
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches.
Journal: Frontiers in oncology
Published: March 22, 2024
BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.
Journal: Frontiers in pharmacology
Published: February 22, 2024
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background.
Journal: International journal of molecular sciences
Published: January 19, 2024
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.
Journal: Cell death & disease
Published: November 09, 2023
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair.
Journal: Cancers
Published: June 28, 2023
Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.
Journal: British journal of cancer
Published: February 16, 2023
Last Updated: 09/26/2026